RISS 검색 - 국내학술지논문 상세보기

다국어 초록 (Multilingual Abstract)

There are limited data on the initial dose of warfarin therapy in outpatients. The
Anti-coagulation Service(ACS) of the Samsung Medical Center(SMC) confirmed that patient age is the most important determinant of warfarin requirement in Korean, and has set up age-related warfarin initial dosage guideline: warfarin 3.5 mg/day for under 50-year-old, 3 mg/day for age
between 51~60, 2.5 mg/day for age between 61~70, 2 mg/day for over 71-year-old patients, followed by checking INR weekly. In the context, the purpose of this study is to analyze the appropriateness of age-related warfarin initial dosage guideline and propose a new dosage protocol.
Study was processed as follows. First, targeted patients who initiated warfarin therapy with age-related warfarin initial dosage guideline(target INR 2.0-3.0) in ACS of our out-patient medical center and had indication of atrial fibrillation were investigated. For the study, 81 patients' records were analysed retrospectively. Before age-related warfarin initial dosage guideline was applied, the average period of achieving therapeutic levels was 32.42 days, on the other hands, 18.07 days for age-related warfarin initial dosage guideline. No patient suffered any thrombotic or hemorrhagic complications during taking age-related warfarin initial dose. The age-related initial warfarin dosage guideline has proposed safe and effective in out-patient warfarinization.
But the group of age between 61~70, it took 5 days longer than other group, and needs increase in initial warfarin dose.
The INR checked within 1 week and the ratio of the warfarin dose of maintaining therapeutic level to initial dose was analysed. The less INR checked within 1 week, need the more warfarin dose to maintain therapeutic level(p<0.0001). All things considered, this study allowed new protocol
for warfarin dose regulation like followings; 100% increase of initial warfarin dose for checked INR under 1.2, 50% increase for INR 1.2~1.4, 30% increase for INR 1.4~1.6, 10~20% increase for INR 1.6~1.8, 10% increase for INR 1.8~1.9, maintain initial dose for INR 1.9~2.0, decrease 10% for INR over 2.0.
The study was designed to the appropriateness of age-related warfarin initial dosage guideline.
The guideline was shortened required period of achieving therapeutic levels. And based on the results, this study proposed a new dosage protocol.

번역하기

참고문헌 (Reference)

1 김희진, "연령별 적정 와파린 용량 설정에 관한 연구" 한국병원약사회 23 (23): 1-16, 2006

2 Dana L. Singla, "Warfarin maintenance dosages in the very elderly" 62 : 1062-1066, 2005

3 "The pharmacology and management of the vitamin K antagonists : the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy" 126 : 204S-233S, 2004

4 Herman D., "The influence of co-treatment with carbamazepine, amiodarone and statins on warfarin metabolism and maintenance dose" 62 (62): 291-296, 2006

5 Wynne H., "The influence of age, liver size and enantiomer concentrations on warfarin requirements" 40 : 203-207, 1995

6 Chan TY., "The determinants of warfarin requirements in Chinese patients" 1 : 281-282, 1992

7 Chan E., "Stereochemical aspects of warfarin drug interaction: use of a combined pharmacokinetic- pharmacodynamic model" 56 : 286-294, 1994

8 S. Janes, "Safe introduction of warfarin for thrombotic prophylaxis in atrial fibrillation requiring only a weekly INR" 26 : 43-47, 2004

9 Demirkan K., "Response to warfarin and other oral anticoagulants : effects of disease states" 93 (93): 448-454, 2000

10 Blann A., "Racial background is a determinant of average warfarin dose required to maintain the INR between 2.0-3.0" 107 : 207-209, 1999